Jeffrey B. Mirviss - EVP&Pres, Periph Intervent at Boston Scientific Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP&Pres, Periph Intervent
Stock Symbol
BSX on NYSE
Industry
Surgical & Medical Instruments & Apparatus
All Insider Reports
All Insider Reports

Jeffrey B. Mirviss - trading volume in the past year for Boston Scientific Corp

Holdings reported by Jeffrey B. Mirviss for Boston Scientific Corp

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 28 K $2.1 M $75.10 May 29, 2024 Direct
Restricted Stock Units 3.33 K $220 K $65.86 Feb 17, 2024 Direct Common Stock
Deferred Stock Units 0 $0 $65.86 Feb 18, 2024 Direct Common Stock
Stock Option (Right to Buy) 0 $0 $17.37 May 29, 2024 Direct Common Stock
Performance Share Units 0 $57.81 Jan 1, 2024 Direct Common Stock

Transactions reported by Jeffrey B. Mirviss for Boston Scientific Corp

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership